Your browser doesn't support javascript.
loading
High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer.
Okamoto, Taiki; Onaga, Chotaro; Matsuoka, Izumi; Ozaki, Ayaka; Matsuda, Chika; Kasai, Takahiro; Xiong, Yuyun; Harada, Yohsuke; Sato, Tsugumichi; Nakano, Yoshio; Mano, Yasunari; Miyazaki, Satoru; Ishiguro, Hitoshi; Sato, Keiko; Tamori, Shoma; Sasaki, Kazunori; Ohno, Shigeo; Akimoto, Kazunori.
Afiliación
  • Okamoto T; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Onaga C; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Matsuoka I; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Ozaki A; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Matsuda C; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Kasai T; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Xiong Y; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Harada Y; Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Sato T; Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Nakano Y; Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Mano Y; Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Miyazaki S; Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Ishiguro H; Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Sato K; Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Tamori S; Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Sasaki K; Department of Urology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Ohno S; Life Science Technology Project, Research and Development Department, Kanagawa Institute of Industrial Science and Technology, Kanagawa, Japan.
  • Akimoto K; Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
Cancer Diagn Progn ; 3(4): 439-448, 2023.
Article en En | MEDLINE | ID: mdl-37405223
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Diagn Progn Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Diagn Progn Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia